Home Crystal structure of O-(3-(benzo[d]thiazol-2-yl)naphthalen-2-yl) O-phenyl carbonothioate, C24H15NO2S2
Article Open Access

Crystal structure of O-(3-(benzo[d]thiazol-2-yl)naphthalen-2-yl) O-phenyl carbonothioate, C24H15NO2S2

  • Qian Wang , Yong-Lang Liu , Jiang-Hai Ye , Juan Zou , Chong Wu ORCID logo EMAIL logo and Wu-De Yang EMAIL logo
Published/Copyright: October 31, 2023

Abstract

C24H15NO2S2, monoclinic, P21/c (no. 14), a = 20.8250(11) Å, b = 5.3649(3) Å, c = 18.8787(11) Å, β = 106.278(2)°, V = 2024.7(2) Å3, Z = 4, Rgt(F) = 0.0439, wRref(F2) = 0.1015, T = 273 K.

CCDC no.: 2301075

Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Yellow block
Size: 0.20 × 0.18 × 0.16 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.28 mm−1
Diffractometer, scan mode: Bruker APEX-II, φ and ω
θmax, completeness: 26.0°, 99 %
N(hkl)measured, N(hkl)unique, Rint: 15,411, 3962, 0.033
Criterion for Iobs, N(hkl)gt: Iobs > 2σ(Iobs), 3094
N(param)refined: 262
Programs: Olex2 [1], Bruker [2], SHELX [3], Diamond [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z Uiso*/Ueq
S1 0.72952 (3) 0.39603 (12) 0.55527 (3) 0.05553 (17)
S2 0.66977 (3) 0.53092 (14) 0.74311 (3) 0.0655 (2)
O1 0.60388 (7) 0.7204 (3) 0.61382 (9) 0.0659 (5)
O2 0.70763 (7) 0.7949 (3) 0.64322 (8) 0.0523 (4)
N1 0.85437 (8) 0.2923 (3) 0.61284 (9) 0.0475 (4)
C1 0.42010 (19) 0.4931 (13) 0.6311 (3) 0.140 (2)
H1 0.3775 0.4471 0.6330 0.168*
C2 0.44948 (18) 0.6971 (10) 0.6679 (2) 0.1252 (16)
H2 0.4277 0.7875 0.6963 0.150*
C3 0.51185 (13) 0.7732 (7) 0.66372 (18) 0.0891 (9)
H3 0.5317 0.9168 0.6877 0.107*
C4 0.54291 (11) 0.6335 (5) 0.62405 (13) 0.0613 (6)
C5 0.66030 (10) 0.6834 (4) 0.66718 (12) 0.0488 (5)
C6 0.77354 (10) 0.8014 (4) 0.69139 (11) 0.0453 (5)
C7 0.82069 (9) 0.6284 (4) 0.67908 (11) 0.0427 (5)
C8 0.80731 (9) 0.4400 (4) 0.62040 (11) 0.0430 (5)
C9 0.83140 (10) 0.1343 (4) 0.55365 (11) 0.0457 (5)
C10 0.86972 (12) −0.0444 (4) 0.53115 (13) 0.0589 (6)
H10 0.9145 −0.0658 0.5568 0.071*
C11 0.84110 (13) −0.1888 (5) 0.47096 (14) 0.0652 (6)
H11 0.8665 −0.3092 0.4558 0.078*
C12 0.77430 (14) −0.1570 (5) 0.43216 (14) 0.0683 (7)
H12 0.7558 −0.2563 0.3911 0.082*
C13 0.76405 (10) 0.1621 (4) 0.51484 (11) 0.0493 (5)
C14 0.73529 (13) 0.0162 (5) 0.45283 (13) 0.0656 (7)
H14 0.6907 0.0367 0.4264 0.079*
C15 0.4519 (2) 0.3553 (9) 0.5917 (3) 0.1287 (16)
H15 0.4314 0.2143 0.5667 0.154*
C16 0.51537 (17) 0.4229 (7) 0.58808 (18) 0.0928 (9)
H16 0.5382 0.3272 0.5620 0.111*
C17 0.78918 (11) 0.9792 (4) 0.74349 (13) 0.0517 (5)
H17 0.7565 1.0911 0.7482 0.062*
C18 0.85467 (11) 0.9983 (4) 0.79121 (12) 0.0491 (5)
C19 0.87377(13) 1.1793 (4) 0.84736 (14) 0.0619 (6)
H19 0.8427 1.2958 0.8534 0.074*
C20 0.93741(14) 1.1848 (5) 0.89274 (15) 0.0693 (7)
H20 0.9494 1.3048 0.9296 0.083*
C21 0.98494 (12) 1.0116 (5) 0.88432 (15) 0.0670 (7)
H21 1.0281 1.0165 0.9160 0.080*
C22 0.96860 (11) 0.8369 (4) 0.83053 (13) 0.0576 (6)
H22 1.0008 0.7240 0.8253 0.069*
C23 0.90292 (10) 0.8240 (4) 0.78208 (12) 0.0467 (5)
C24 0.88446 (10) 0.6464 (4) 0.72581 (11) 0.0468 (5)
H24 0.9168 0.5352 0.7197 0.056*

1 Source of materials

The synthesis consists of two steps. In the first step, PCl3 (3 ml) was added dropwise to a solution of 3-hydroxynaphthalene-2-carboxylic acid (6 g) and 2-aminothiophenol (4 ml) in toluene (50 ml). Reflux the mixture for 2 h. Toluene was removed by vacuum distillation and the solid remained was collected and purified by recrystallization from methanol. The product was obtained as yellow crystals. In the second step, the mixture of 3-(benzo[d]thiazol-2-yl)naphthalen-2-ol (1 g), phenyl chlorothionocarbonate (1 g), DIPEA (1 ml) in 20 ml DCM were stirred at room temperature for 24 h. Then, the solvent was evaporated and the crude was purified via column chromatography using hexane/ethyl acetate (10:1, v/v) to gain the final product as a white solid. Colourless crystals were grown by slow evaporation of the hexane solution.

2 Experimental details

Using Olex2 [1], the structure was solved using Charge Flipping and refined with the ShelXL [3] refinement. All hydrogen atoms were positioned geometrically, with the d(C–H) = 0.97–0.99 Å, Uiso(H) = 1.2 times Ueq(C) and Uiso(H) = 1.5 times Ueq(O).

3 Comment

Benzothiazole (BTA) and its derivatives are the most important heterocyclic compounds, which are widespread and essential components of a variety of natural products and pharmaceutical agents [5], [6], [7]. Benzothiazoles are the appropriate source for fragments and core scaffolds for the design and synthesis of targeted molecules due to their innate affinity for a variety of biological receptors [8, 9]. Benzothiazole derivatives have been extensively used in various fields, such as pharmaceutical industry, and dye industry [10]. The bond length and bond angle of the target compound are within the normal range [11]. The benzothiazole ring is nearly parallel to the benzene ring, with a dihedral angle of 3.76°. The dihedral angle between the benzene ring and the naphthalene ring is 39.68°.


Corresponding authors: Chong Wu and Wu-De Yang, College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, People’s Republic of China, E-mail: (C. Wu), (W.-D. Yang)

Funding source: Guizhou Provincial Key Technology R&D Program

Award Identifier / Grant number: [2020]4Y107

Funding source: the Natural Science Research Project of Education Department of Guizhou Province

Award Identifier / Grant number: (No. QJH-KY-[2021]068)

Funding source: Doctor Startup Funds of Guizhou University of Traditional Chinese Medicine

Award Identifier / Grant number: [2018]04

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: Guizhou Provincial Key Technology R&D Program [2020]4Y107, the Natural Science Research Project of Education Department of Guizhou Province (No. QJH-KY-[2021]068) and Doctor Startup Funds of Guizhou University of Traditional Chinese Medicine [2018]04.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar

2. Bruker. APEX2, SAINT and SADABS; Bruker AXS Inc.: Madison, WI, USA, 2012.Search in Google Scholar

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

4. Brandenburg, K. DIAMOND. Visual Crystal Structure Information System. Ver. 4.0; Crystal Impact: Bonn, Germany, 2015.Search in Google Scholar

5. Das, S., Indurthi, H. K., Asati, P., Saha, P., Sharma, D. K. Benzothiazole based fluorescent probes for the detection of biomolecules, physiological conditions, and ions responsible for diseases. Dyes Pigment 2022, 199, 110074; https://doi.org/10.1016/j.dyepig.2021.110074.Search in Google Scholar

6. Malah, T. E., Hegab, M. I., Awad, H. M., Abdelrahman, M. T., Abdel-Megeid, F. M. E., Shamroukh, A. H., Mageid, R. E. A., Nour, H. F. Benzothiazole-tethered 1,2,3-triazoles: synthesis, antimicrobial, antioxidant, and molecular docking studies. J. Mol. Struct. 2022, 1266, 133417; https://doi.org/10.1016/j.molstruc.2022.133417.Search in Google Scholar

7. Zheng, S., Fang, Y., Chen, Y., Kong, Q., Wang, F., Chen, X. Benzothiazole derivatives based colorimetric and fluorescent probes for detection of amine/ammonia and monitoring the decomposition of urea by urease. Spectrochim. Acta A 2022, 267, 120616; https://doi.org/10.1016/j.saa.2021.120616.Search in Google Scholar PubMed

8. Qin, J. C., Li, Z. W., Fu, Z. H., Zhang, Z. H. Development of a NIR fluorescent probe for detection of cysteine and its application in bioimaging. Sens. Actuators B 2022, 357, 131430; https://doi.org/10.1016/j.snb.2022.131430.Search in Google Scholar

9. Korkmaz, A., Bursal, E. Benzothiazole sulfonate derivatives bearing azomethine: synthesis, characterization, enzyme inhibition, and molecular docking study. J. Mol. Struct. 2022, 1257, 132641; https://doi.org/10.1016/j.molstruc.2022.132641.Search in Google Scholar

10. Sun, Y., Tang, X., Li, X., Kong, X., Tian, M., Wang, Y., Dong, B. PET–ESIPT-based fluorescent probes for revealing the fluctuation of peroxynitrite (ONOO−) in living cells, zebrafishes and brain tissues. Sens. Actuators B 2022, 353, 131121; https://doi.org/10.1016/j.snb.2021.131121.Search in Google Scholar

11. Buguis, F. L., Boyle, P. D., Gilroy, J. B. Benzothiazole-substituted boron difluoride formazanate dyes. Dyes Pigments 2022, 198, 110002; https://doi.org/10.1016/j.dyepig.2021.110002.Search in Google Scholar

Received: 2023-09-11
Accepted: 2023-10-13
Published Online: 2023-10-31
Published in Print: 2023-12-15

© 2023 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of bis(dimethylammonium) poly[(μ4-1,1′-(1,4-phenylenebis(methylene))bis(1H-pyrazole-3,5-dicarboxylato))-κ6O1, N2:O2:O3:O1′,N2′]nickel (II)], C22H26N6NiO8
  4. Hydrothermal synthesis and crystal structure of catena-poly[diaqua-bis(μ2-4-((pyridin-4-ylmethyl)amino)benzoato-κ2N:O)cobalt(II)] 4,4′-bipyridine – water (1/2/2)
  5. Crystal structure of (2S,3S,4S,5S, Z)-2,3,5,6-tetrakis(benzyloxy)-4-hydroxyhexanal oxime, C34H37NO6
  6. The crystal structure of hexakis(3-thiophenecarboxylato-κ2O,O″)-bis(1,10-phenanthroline-κ2N,N′) trimanganese(II), C54H34N4O12S6Mn3
  7. Crystal structure of catena-poly[(μ2-1,4-di(pyridin-4-yl)benzene-κ2N:N′)-(4-bromobenzoate-κ2O:O′)-(μ-2-bromobenzoate-κ2O,O′)nickel(II)] – water (2/1), C30H21Br2N2NiO4.5
  8. The crystal structure of poly[(μ3-1,3-phenylenedioxydiacetate-κ5O,O,O′,O″,O‴)-bis(4′-(4-(1H-imidazol-1-yl)phenyl)-4,2′:6′,4″-terpyridine-kN) cadmium(II)], C58H42CdN10O6
  9. The crystal structure of 5-chloro-6′-methyl-3-(4-(methylsulfonyl)phenyl)-[2,3′-bipyridin]-1′-ium 4-methylbenzenesulfonate
  10. Crystal structure of poly[(μ-benzoato)-(μ-cis-4–hydroxy-D-proline)lithium], C12H14LiNO5
  11. The crystal structure of catena-poly[aqua-(4-iodopyridine-2,6-dicarboxylato-κ3N,O,O)-copper(II)] monohydrate, C7H6NO6ICu
  12. The crystal structure of catena-[diaqua-(4-acetylphenoxyacetato-κ2O,O)-bis(4-acetylphenoxyacetato-κ3O,O:O)-dihydrate-lanthanum(III)]–4,4′-bipyridine (2/1), C35H35NO14La
  13. The crystal structure of catena-poly[(4-iodopyridine-2,6-dicarboxylato-κ4 O,N,O′,O′′)(4-imidazol-1-yl-pyridine-κN)copper(II)], C15H9N4O4ICu
  14. Crystal structure of polybis(μ 4-3,5-dicarboxylatopyrazol-1-yl)-bis(N,N-dimethylformamide)tri-copper(II)–acetonitrile (1/2), C20H22Cu3N8O10
  15. Crystal structure of poly[(μ2-5-hydroxy-isophthalato-κ4O,O′:O″,O‴)-(μ2-1,5-bis(imidazol-2-methyl)pentane-κ2N:N′)cadmium(II)], C21H24CdN4O5
  16. The crystal structure of poly[bis(μ2-1,4-bi(1-imidazolyl)benzene-κ2N:N′)bis(μ2-4,4′-methylenebis(3-hydroxy-2-naphthoate)-κ2O:O′)cobalt(II)], C35H24CoN4O6
  17. The crystal structure of a cobalt-vanadium-oxido hydrate
  18. The crystal structure of catena-poly[(μ 2-2H-1,2,3-triazole-4,5-dicarboxylato-κ 2 O, O′)-(μ 2-1,3-bis((1H-imidazol-1-yl)methyl)benzene-κ 2 N,N′) zinc(II)], C18H15N7O4Zn
  19. Crystal structure of poly[diaqua-(bis(m2-1,4-bis(imidazol-1-ylmethyl)benzene)-κ2N,N′-manganese] dichloride, C28H32MnN8O2Cl2
  20. The crystal structure of 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino [3,2-a]isoquinolin-7-ium (E)-3-(4-nitrophenyl)acrylate pentahydrate, C29H34N2O13
  21. Crystal structure of poly[(μ6-ammoniotris(methylene))tris(hydrogen phosphonato)cadmium(II)], C3H10CdNO9P3
  22. Crystal structure of Zn2[(1,1′-(hexane-1,6-diyl)bis(3-(pyridin-3-yl)urea))·(H2O)2·(DMF)2·(SO4)2], C24H50N8O18S2Zn2
  23. The crystal structure of 2-anilino-1,4-naphthoquinone, C10H11NO2
  24. Crystal structure of (E)-2-(2-(4-(diethylamino)styryl)-1-ethyl-1,4-dihydroquinolin-4-yl) malononitrile, C26H26N4
  25. Crystal structure of ethyl 2-((2,6-dichloro-4-(cyanomethyl)phenyl) amino)benzoate, C17H14Cl2N2O2
  26. Synthesis and crystal structure of 2-(3-oxo-3-phenylpropyl)isoindoline-1,3-dione, C17H13NO3
  27. The crystal structure of bis(acetonitrile-κ1N)tetrakis(μ2-2,6-difluorobenzoato-κ2O:O′)rhodium(II) (Rh–Rh), C32H18F8O8N2Rh2
  28. The crystal structure of a new polymorph of 6-hydroxy-2-naphthoic acid, C11H8O3
  29. The crystal structure of [(8-carboxymethoxy-quinoline-2-carboxylate-κ4N,O,O,O)-2,2′-bipyridine-κ2N-copper(II)] tetrahydrate, C22H23N3O9Cu
  30. The crystal structure of ethyl 4-hydroxy-2-(4-methoxyphenyl)-5-oxo-1-(2-oxo-2H-chromen-6-yl)-2,5-dihydro-1H-pyrrole-3-carboxylate, C23H19NO7
  31. Crystal structure of 7-hydroxy-3,4-dihydronaphthalen-1(2H)-one, C10H10O2
  32. Crystal structure of bis(tetrapropylammonium) dodecacarbonyltetratelluridotetraferrate(2-), (Pr4N)2[Fe4Te4(CO)12]
  33. The crystal structure of poly[bis(μ2−3−aminopyridine−4−carboxylatoκ2N:O)Zinc(II)], [Zn(C6H5N2O2)2] n
  34. The crystal structure of methyl 5-nitro-2-(tosyloxy)benzoate, C15H13NO7S
  35. The crystal structure of 18-crown-6 ― tetraaqua-dichlorido-di-μ2-chloridodicopper(II) (2/1), C12H32O10Cu2Cl4
  36. Crystal structure of 6,6a,7,8,9,10-hexahydro-5H-pyrazino [2,3-e]pyrido[1,2-a]pyrazine, C10H14N4
  37. Crystal structure of catena-poly-{diaqua-bis[μ-(((4-chlorophenyl)sulfonyl)glycinato-κO)](μ2-4, 4′-bipyridine-κ2N:N′)cobalt(II)} dihydrate, C26H30Cl2CoN4O12S2
  38. Crystal structure of bis{N′-[1,3-diphenylprop-2-en-1-ylidene]-N-phenylcarbamohydrazonothioato}zinc(II), C44H36N6S2Zn
  39. Crystal structure of tetraaqua-bis(((4-chlorophenyl)sulfonyl)glycinato-κO)cobalt(II) dihydrate, C16H26Cl2CoN2O14S2
  40. Crystal structure of 2-(5-phenyl-1-(quinolin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenol, C24H19N3O
  41. Crystal structure of 2-((2-fluoro-4-(trifluoromethyl)phenyl)(hydroxy)methyl)-7-methoxy-3,4-dihydronaphthalen-1((2H))-one, C19H16F4O3
  42. Crystal structure of 2-amino-4-(2-fluoro-3-(trifluoromethyl)phenyl)-9-methoxy-1,4,5,6-tetrahydrobenzo[h]quinazolin-3-ium chloride, C20H18ClF4N3O
  43. Crystal structure of (2-phenylimino methylquinoline-κ 2 N,N′)-bis(1–phenylpyrazole-κ 2 C,N)-iridium(III) hexafluorophosphate, C34H26F6IrN6P
  44. Crystal structure of (3-hydroxy-4-methoxyphenyl)(pyrrolidin-1-yl)methanone, C12H15NO3
  45. The crystal structure of bis(trimethylsulfoxonium) catena-poly[µ2-hexabromido-indium(III)sodium(I)] C6H18O2S2NaInBr6
  46. Crystal structure of N-cyclopropyl-3-hydroxy-4-methoxybenzamide, C11H13NO3
  47. The crystal structure of (bis(benzimidazol-2-yl-methyl)amine-κ3N,N,N )-(dihydrogen L-malate-κ2O,O )copper(II) perchlorate dihydrate, CuC20H24ClN5O12
  48. Crystal structure of (1E,1′E)-4,4′-(9,9-diethyl-9H-fluorene-2,7-diyl)dibenzaldehyde dioxime, C31H28N2O2
  49. Crystal structure of diethyl 1,9-bis(4-fluorophenyl)-4,6-diphenylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta [b]pyridine-3,7(2H)-dicarboxylate, C40H36F2N2O4
  50. Crystal structure of bis(benzene-1 carboxylato-O 3,5-carboxyl-κ1O)-[(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)nickel(II) ─ benzene-1,3,5-tricarboxylic acid ─ water (1/2/4), C52H66N4NiO28
  51. Crystal structure of 1,4-dibromo-2,5-bis(2-methoxyethoxy)benzene-1,4-diol, C12H16Br2O4
  52. Crystal structure of dicarbonyl[N,N′-(1,2-dimethyl-1,2-ethanediylidene)bis[2,6-bis(1-methylethyl)benzenamine]-N,N′]nickel(0), C30H40N2NiO2
  53. Crystal structure of 1,4-dibromo-2,5-bis(prop-2-yn-1-yloxy)benzene, C12H8Br2O2
  54. Crystal structure of O-(3-(benzo[d]thiazol-2-yl)naphthalen-2-yl) O-phenyl carbonothioate, C24H15NO2S2
  55. The crystal structure of (E)-4-fluoro-N′-(1-(4-hydroxyphenyl)propylidene)benzohydrazide, C16H15FN2O2
  56. Crystal structure of (E)-1-(benzo[d]thiazol-2-yl)-N-(4,5-dihydropyren-2-yl)methanimine, C24H16N2S
  57. Crystal structure of 3-((4-bromophenyl)thio)-1H-indole, C14H10BrNS
  58. Synthesis and crystal structure of 1-((7-hydroxy-3-(4-hydroxy-3-nitrophenyl)-4-oxo-4H-chromen-8-yl)methyl)piperidin-1-ium-4-carboxylate monohydrate, C22H22N2O9
  59. Synthesis and crystal structure of (3E,5S,10S,13S,14S,17Z)-17-ethylidene-10,13-dimethylhexadecahydro-3H-cyclopenta[α]phenanthren-3-one O-(methacryloyl) oxime, C50H74N2O4
  60. Crystal structure of the hydrogen storage active phase La12Mg46LiMn
  61. The crystal structure of the salt: 4-((1,3-dioxoisoindolin-2-yl)carbamoyl)pyridine-1-ium 2-carboxybenzoate, C14H10N3O3·C8H5O4
  62. Crystal structure of (2-(2-pyridine)-benzimidazole-κ2 N,N′)-bis(1-phenylpyrazole-κ2 C,N)iridium(III) hexafluorophosphate, C30H22F6IrN7P
  63. Crystal structure of dichlorido-bis[2-(2,4-difluorophenyl)pyridine-κ1N]platinum(II), C22H14Cl2F4N2Pt
  64. Crystal structure of (5R,8R,9R,10R,12R,13R,14R, 17S,17Z)-2-((3-fluoropyridin-4-yl)methylene)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)hexadecahydro-3H-cyclopenta[a]phenanthren-3-one, C36H52FNO3
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2023-0403/html
Scroll to top button